Skip to content
Clinical Trials – home

Vulvovaginal pain Life with Disease

1 / 1 trials open to patients1 country

In short

Vulvovaginal pain is a condition that can profoundly affect a woman's quality of life, yet many who experience it struggle in silence, unsure of where to turn or whether their pain is truly understood.

Key points

  • Vulvodynia affects approximately 8 to 16 percent of women during their lifetime, making it far more common than many people realize, yet it remains significantly underdiagnosed.
  • The condition can occur at any age but most commonly affects women between 20 and 60 years old, and it is the leading cause of painful intercourse among women in their reproductive years.
  • Most women with vulvodynia experience substantial improvement with treatment, though finding the right approach may require trying multiple therapies and exercising considerable patience.
  • Pelvic floor physical therapy and cognitive behavioral therapy are considered first-line treatments supported by international consensus guidelines, often working better when combined with other interventions.
  • Simple lifestyle modifications—such as wearing cotton underwear, avoiding scented products, using lubricants during sex, and applying ice packs after activities—can significantly reduce symptoms for many women.
  • The pain of vulvodynia is real and physical, not psychological, though chronic pain can certainly affect mental health and benefit from psychological support as part of comprehensive treatment.
  • Women with vulvodynia who participate in clinical trials contribute valuable data that helps researchers develop better treatments, even if they don't experience personal benefit from the experimental therapy.
  • Family support—including understanding the condition, assisting with practical needs, and maintaining patience throughout the treatment process—plays a crucial role in helping women manage this challenging condition effectively.

Understanding the Outlook for Vulvovaginal Pain

When someone receives a diagnosis of vulvovaginal pain, particularly vulvodynia—which is chronic vulvar pain lasting three months or more without a clear identifiable cause—the path forward can feel uncertain. The prognosis for this condition is genuinely encouraging, though it requires patience and often involves trying multiple approaches before finding what works best for each individual person.

Many women experience substantial improvement when they engage with appropriate treatment, and it is important to understand that vulvodynia is not a progressive disease that inevitably worsens over time. In fact, for some women, vulvodynia can resolve on its own without intervention, though this cannot be predicted or relied upon. Research shows that most women who pursue treatment do experience meaningful relief from their symptoms, though rapid resolution is unusual even with appropriate therapy.

The condition affects women across all age groups, from young women in their twenties to those in their sixties and beyond, though most diagnoses occur in women between ages 20 and 60. This chronic pain condition is far more common than many people realize—studies suggest that approximately 8 to 16 percent of women will experience vulvodynia at some point in their lifetime, which translates to millions of women worldwide.

It is crucial to understand that while the condition can last for months or even years, the majority of women who work with healthcare specialists and commit to a treatment plan find that their pain decreases significantly. Some women achieve complete relief, while others learn to manage their symptoms effectively so that the pain no longer controls their daily activities. The key factor in a positive outcome is often persistence—being willing to try different treatments and approaches until the right combination is found.

How Vulvovaginal Pain Develops Without Treatment

Understanding what happens when vulvovaginal pain goes untreated helps illustrate why seeking care is so important. When vulvar pain persists without intervention, several patterns can emerge that make the condition more challenging to address over time.

The pain associated with vulvodynia often begins subtly and may initially be dismissed as temporary irritation or the result of an infection. Without proper diagnosis and treatment, this pain can establish itself as a chronic condition. The nervous system can become increasingly sensitized, meaning that the nerves in the vulvar area may begin to overreact to stimuli that wouldn't normally cause pain. This process, called nerve hypersensitivity, can make the vulva feel as though it is constantly under threat, sending pain signals even when there is no actual injury or infection present.

Over time, untreated vulvar pain can lead to changes in the pelvic floor muscles. These muscles, which support the pelvic organs and play a role in sexual function and urination, may begin to tighten or spasm in response to ongoing pain. This muscle tension becomes a secondary source of discomfort, creating a cycle where pain leads to muscle tightness, which in turn causes more pain. This pattern can persist and worsen without appropriate intervention such as pelvic floor physical therapy.

Women who do not seek treatment may also experience progressive psychological impacts. Chronic pain that affects intimate areas of the body can lead to avoidance of sexual activity, which may strain romantic relationships. The inability to engage in previously enjoyable activities—such as exercise, wearing certain types of clothing, or sitting for extended periods—can lead to social isolation and feelings of frustration or hopelessness.

Research has shown that many women with untreated vulvodynia visit multiple doctors over several years before receiving an accurate diagnosis. In one study, 60 percent of women seeking treatment had already visited three or more doctors for their symptoms without getting proper answers. This delay in diagnosis means that women suffer longer than necessary and may develop more complex patterns of pain and dysfunction that require more extensive treatment.

Potential Complications That May Arise

While vulvovaginal pain itself is not life-threatening, it can lead to several complications that significantly affect a woman's overall wellbeing. These complications often develop gradually and may not be immediately obvious as being connected to the original vulvar pain.

One of the most common complications is the development of pelvic floor muscle dysfunction. When someone experiences ongoing pain in the vulvar region, the muscles of the pelvic floor often respond by tightening or going into spasm. This protective response is the body's attempt to guard against further pain, but it becomes problematic when it persists. Hypertonic, or overly tight, pelvic floor muscles can cause additional pain during intercourse, difficulty with urination, and discomfort with bowel movements.

Sexual dysfunction is another significant complication. Many women with vulvodynia experience pain during sexual intercourse, a condition called dyspareunia. This pain can be so severe that penetration becomes impossible. Over time, even the anticipation of pain can trigger the pelvic floor muscles to tighten involuntarily, creating a condition called vaginismus where the vaginal muscles contract and prevent entry. These complications can lead to relationship difficulties, reduced intimacy, and feelings of inadequacy or guilt.

Mental health complications are also common among women living with chronic vulvar pain. Studies have linked vulvodynia to higher rates of depression and anxiety. The constant nature of chronic pain, combined with its intimate location and the challenges it creates in daily life, can be emotionally exhausting. Women may feel isolated because the condition is difficult to discuss openly, and they may worry that others won't understand or believe their experience of pain.

Sleep disturbances represent another complication that can affect overall health. Persistent pain, particularly when it is constant rather than intermittent, can make it difficult to fall asleep or stay asleep throughout the night. Poor sleep quality then contributes to increased pain sensitivity, fatigue, difficulty concentrating, and mood changes, creating yet another cycle that compounds the original problem.

Some women develop secondary skin problems due to repeated application of over-the-counter treatments or from scratching irritated areas. Others may experience complications from repeated courses of antifungal medications taken for presumed yeast infections that were never actually present. These unnecessary treatments can cause further irritation and may disrupt the natural balance of bacteria and yeast in the vaginal area.

Impact on Daily Life and Functioning

Vulvovaginal pain reaches into virtually every aspect of a woman's daily existence, often in ways that those who have not experienced it might not immediately understand. The condition affects physical comfort, emotional wellbeing, social interactions, work performance, and intimate relationships in profound ways.

Simple daily activities that most people take for granted can become sources of significant discomfort. Sitting for extended periods—whether at a desk for work, during a commute, or while enjoying a meal with friends—can trigger or worsen pain. Many women with vulvodynia find that they cannot sit comfortably for more than short periods, which creates challenges in office jobs, during air travel, or at social gatherings. Some learn to use specialized cushions, such as donut-shaped pillows, while others must stand frequently or adjust their positions constantly.

Physical exercise and recreational activities often require modification or abandonment. Activities that put direct pressure on the vulvar area—such as cycling, horseback riding, or certain gym exercises—may be impossible or may trigger painful flare-ups. Even lower-impact activities like walking or swimming can sometimes cause discomfort, particularly if they create friction in the affected area or involve exposure to chlorinated pool water.

Clothing choices become limited. Tight pants, jeans, synthetic underwear, or pantyhose can all worsen symptoms, leading many women to wear only loose-fitting clothing and cotton undergarments. In professional environments where certain dress codes are expected, this limitation can create awkward situations or require difficult conversations with employers.

Intimate relationships face particular strain. The pain associated with sexual intercourse can make this aspect of a relationship extremely challenging or impossible. Partners may feel rejected, confused, or helpless, while the woman experiencing pain may feel guilty, broken, or inadequate. Communication about the condition becomes essential but can be emotionally difficult for both individuals involved. The inability to be physically intimate can affect the emotional connection between partners and may lead to relationship conflict or dissolution if not addressed with understanding and patience.

Basic hygiene practices require adjustment. Women with vulvodynia must avoid scented soaps, bubble baths, feminine hygiene products, and even certain laundry detergents that can irritate sensitive tissue. Using tampons during menstruation may be painful or impossible, requiring the use of pads instead. Even urination can trigger burning sensations, leading some women to rinse with cool water after using the bathroom.

Work performance can suffer in multiple ways. Difficulty sitting comfortably may reduce productivity and concentration. Pain and poor sleep can lead to fatigue and difficulty focusing on tasks. Some women need to take sick days during particularly severe flare-ups. The need for frequent medical appointments to find effective treatment can also interfere with work schedules. For some women, the condition becomes severe enough that they must reduce their work hours or seek disability accommodations.

Social activities may be curtailed. Women with vulvodynia might decline invitations to events that require prolonged sitting, such as concerts, movies, or dinner parties. They may avoid swimming, group exercise classes, or other recreational activities where their clothing limitations or need for frequent position changes might draw attention or questions. This social withdrawal can lead to feelings of isolation and can strain friendships.

The emotional toll encompasses frustration, anxiety, fear, sadness, and sometimes anger. Many women describe feeling that their body has betrayed them or that they are somehow damaged. The chronic nature of the condition, combined with the often-lengthy process of finding effective treatment, can lead to feelings of hopelessness. However, with proper support—including therapy, support groups, and compassionate healthcare providers—most women develop resilience and learn to cope effectively with their condition.

Supporting Family Members Through Clinical Trials

Families play a crucial role in supporting women who are dealing with vulvovaginal pain, and this support can extend to participation in clinical trials. Understanding what clinical trials are and how they might benefit someone with this condition helps families provide informed support and encouragement.

Clinical trials are research studies that test new treatments, medications, devices, or approaches to managing health conditions. For vulvodynia and vulvovaginal pain, clinical trials might investigate new pain medications, topical treatments, physical therapy techniques, psychological interventions, or combinations of therapies. These studies are essential for advancing medical knowledge and developing better treatment options for future patients.

Family members can help by first educating themselves about the condition. Many women with vulvodynia feel that their pain is dismissed or not taken seriously, even by those closest to them. When family members take the time to learn about the condition—reading reputable medical information, understanding that the pain is real and physical, and recognizing how it affects daily life—they provide validation that can be deeply meaningful to the person experiencing pain.

When it comes to clinical trials specifically, families can assist in several practical ways. They can help search for relevant trials by looking at clinical trial databases, contacting research institutions that specialize in pelvic pain or women's health, or asking healthcare providers about ongoing studies. Since women with chronic pain may feel overwhelmed or discouraged, having a family member who takes on some of this research and organizational work can be immensely helpful.

Transportation and accompaniment to medical appointments related to clinical trials represent another important form of support. Clinical trials often require more frequent visits than standard care, and these appointments may involve evaluations, questionnaires, or treatment sessions. Having a family member available to provide transportation or to accompany the patient can make participation more feasible and less stressful.

Emotional support throughout the trial participation is equally important. Clinical trials can be lengthy, and the woman participating may not experience immediate improvement—particularly if she is assigned to a placebo group or if the treatment being studied doesn't work well for her individual case. Family members who offer encouragement, listen without judgment, and remind the patient that her participation is contributing to important research can help sustain motivation.

Families should also understand the informed consent process for clinical trials. This means the patient will be thoroughly informed about what participation involves, including potential risks, benefits, time commitments, and the right to withdraw at any time. Family members can attend these discussions and help ask questions or remember important details that might be discussed.

Partners, in particular, should recognize that participation in a clinical trial—especially one testing treatments for sexual pain—may require their cooperation and understanding. Some trials might involve questionnaires about sexual function or relationship satisfaction. Partners who approach these aspects of research with patience and openness contribute significantly to successful participation.

It is worth noting that while clinical trials offer the potential for accessing new treatments before they are widely available, they are not guaranteed to provide benefit to individual participants. Families should maintain realistic expectations while still supporting their loved one's decision to contribute to research that may help other women in the future. This perspective—that participation has value even if it doesn't result in personal symptom improvement—can help families remain positive throughout the trial experience.

Financial considerations may also come into play. While many clinical trials provide treatment and assessments at no cost, and some even offer compensation for time and travel, participation can still involve missed work or childcare expenses. Families who can help offset these practical costs or assist with household responsibilities during busy trial periods provide crucial support that makes participation possible.

Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Lidocaine gel – A topical anesthetic medication that can be applied to the vulva to provide numbness and reduce pain in the affected area
  • Tricyclic antidepressants – Medications originally developed for depression that are used at lower doses to help reduce nerve hypersensitivity and chronic pain
  • Gabapentin (Neurontin) – An anticonvulsant medication that can help relieve nerve pain symptoms associated with vulvodynia
  • Desipramine – A tricyclic antidepressant that has been studied for vulvodynia treatment, though research has shown mixed results
  • Selective serotonin reuptake inhibitors (SSRIs) – Antidepressant medications that may provide symptomatic relief for vulvodynia
  • Diazepam (transvaginal) – A benzodiazepine with muscle relaxing properties that can be applied vaginally to help relieve pelvic floor muscle spasms
  • Botox (botulinum toxin) – A neurotoxin that can be injected into pelvic floor muscles to induce localized muscle relaxation and pain relief
  • Topical estrogen – Hormone cream that may be applied to the vestibule to address potential hormone deficiency contributing to vulvar pain
  • Topical capsaicin cream – A cream containing the active component of chili peppers that may help reduce vulvar pain through its effects on pain nerves

Did you know?

  1. Despite affecting up to 16 percent of women at some point in their lives, approximately 60 percent of women with vulvodynia must visit three or more doctors before receiving an accurate diagnosis, highlighting how frequently this condition is overlooked or misunderstood in medical practice.
  2. Some research suggests that women with vulvodynia may be born with a greater number of nerve endings in the vulvar vestibule area, which could make this region more susceptible to becoming hypersensitive if those nerves are damaged or irritated later in life.
  3. Vulvodynia is considered a diagnosis of exclusion, meaning doctors must rule out all other possible causes of vulvar pain—including infections, skin conditions, and other specific disorders—before confirming that someone has vulvodynia, making the diagnostic process sometimes lengthy and complex.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Vulvovaginal pain

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Nomegestrol Acetate
  • Sponsor:Aarhus University Hospital
See all 1 trials →filters applied: condition = Vulvovaginal pain

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).